A

Active Director Director DIN 07423462
DIN 07423462 First appointment Oct 2016 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2016
Shareholding value •••• Premium profile

About Abilash

Data last updated:

Abilash is a Director at Sreekumar & Abilash Health Care Private Limited (since 2016). The company operates in Healthcare. Sreekumar & Abilash Health Care Private Limited reported revenue of ₹1.32 Cr (FY 2023).

DIN 07423462
Primary Designation Director
Industry Healthcare
First Appointment 12 Oct 2016
Oldest Company Age 11 yrs
Largest company Sreekumar & Abilash Health Care Private Limited · ₹1.32 Cr (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Oct 20162015₹1.32 Cr (FY 2023)Active

Directorship timeline

Open interactive timeline →
Sreekumar & Abilash Health Care Private Limited
Premium access

Shareholding and investment profile for Abilash

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abilash

Abilash currently holds 1 directorship: Sreekumar & Abilash Health Care Private Limited (Director, since 12 Oct 2016, revenue ₹1.32 Cr (FY 2023)).

Abilash was first appointed on 12 Oct 2016 as Director at Sreekumar & Abilash Health Care Private Limited.

The current boards of Abilash's companies include Dhanya Urppakkandy (Sreekumar & Abilash Health Care Private Limited), Mohamed Faizal Melethil (Sreekumar & Abilash Health Care Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available